CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 52507-52893 JSONTXT

Annnotations TAB JSON ListView MergeView

CORD-19-Sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T303 0-386 Sentence denotes In 2007, Kimata and co-workers [118] reported the synthesis and assessment of multiple PrP-res accumulation inhibitors according to the structure of edaravone, in which the most potent compound 163 (Fig. 16 ) displayed PrP-res inhibitory effect in the ScN2a cells with IC 50 value of 3 nM, which was 130 times more active than quinacrine and more than 300-fold effective than edaravone.
T91220 0-386 Sentence denotes In 2007, Kimata and co-workers [118] reported the synthesis and assessment of multiple PrP-res accumulation inhibitors according to the structure of edaravone, in which the most potent compound 163 (Fig. 16 ) displayed PrP-res inhibitory effect in the ScN2a cells with IC 50 value of 3 nM, which was 130 times more active than quinacrine and more than 300-fold effective than edaravone.

CORD-19_Custom_license_subset

Id Subject Object Predicate Lexical cue
T17 0-386 Sentence denotes In 2007, Kimata and co-workers [118] reported the synthesis and assessment of multiple PrP-res accumulation inhibitors according to the structure of edaravone, in which the most potent compound 163 (Fig. 16 ) displayed PrP-res inhibitory effect in the ScN2a cells with IC 50 value of 3 nM, which was 130 times more active than quinacrine and more than 300-fold effective than edaravone.